AVROBIO Inc

Company Profile

AVROBIO Inc had its IPO on 2018-06-21 under the ticker symbol AVRO.

The company operates in the Healthcare sector and Biotechnology industry. AVROBIO Inc has a staff strength of 78 employees.

Stock update

Shares of AVROBIO Inc opened at $1.6 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.57 - $1.61, and closed at $1.57.

This is a -2.48% slip from the previous day's closing price.

A total volume of 288,381 shares were traded at the close of the day’s session.

In the last one week, shares of AVROBIO Inc have increased by +1.29%.

AVROBIO Inc's Key Ratios

AVROBIO Inc has a market cap of $46.31 million, indicating a price to book ratio of 0.3548 and a price to sales ratio of 0.

In the last 12-months AVROBIO Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-99867000. The EBITDA ratio measures AVROBIO Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AVROBIO Inc’s operating margin was 0% while its return on assets stood at -48.98% with a return of equity of -102.99%.

In Q1, AVROBIO Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

AVROBIO Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AVROBIO Inc’s profitability.

AVROBIO Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.6188. Its price to sales ratio in the trailing 12-months stood at 0.

AVROBIO Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$83.01 million

Total Liabilities

$11.67 million

Operating Cash Flow

$-8000.00

Capital Expenditure

$8000

Dividend Payout Ratio

0%

AVROBIO Inc ended 2024 with $83.01 million in total assets and $0 in total liabilities. Its intangible assets were valued at $83.01 million while shareholder equity stood at $53.00 million.

AVROBIO Inc ended 2024 with $0 in deferred long-term liabilities, $11.67 million in other current liabilities, 4000.00 in common stock, $-514389000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $72.33 million and cash and short-term investments were $72.33 million. The company’s total short-term debt was $2,627,000 while long-term debt stood at $15.36 million.

AVROBIO Inc’s total current assets stands at $72.33 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $270000.00 compared to accounts payable of $591000.00 and inventory worth $0.

In 2024, AVROBIO Inc's operating cash flow was $-8000.00 while its capital expenditure stood at $8000.

Comparatively, AVROBIO Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.57

52-Week High

$1.93

52-Week Low

$0.56

Analyst Target Price

$3.9

AVROBIO Inc stock is currently trading at $1.57 per share. It touched a 52-week high of $1.93 and a 52-week low of $1.93. Analysts tracking the stock have a 12-month average target price of $3.9.

Its 50-day moving average was $1.45 and 200-day moving average was $1.12 The short ratio stood at 2.59 indicating a short percent outstanding of 0%.

Around 265.9% of the company’s stock are held by insiders while 5286.5% are held by institutions.